Bills / S. 3267
S. 3267
ASAP Act
In plain English
Alzheimer's Screening and Prevention Act or the ASAP Act This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.
Congressional Research Service summary from Congress.gov (not yet simplified).
Sponsor and status
Loading from Congress.gov…
How South Carolina voted
No recorded roll-call vote on this bill yet. Most bills never get one.
Who lobbied
Lobbying reports name the bills a client worked on. They don't say which side anyone took.
No lobbying reported on this bill in the reports we have loaded (January 2025 through September 2026). Lobbyists report each quarter, about 20 days after it ends, so any lobbying since October 2026 will be added once those reports are filed.